Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CMS

CorMedix Eyes REZZAYO Expansion as DefenCath Reimbursement Shift Looms

CorMedix (NASDAQ:CRMD) CEO Joe said the company is preparing for several potential commercial and regulatory catalysts across its infectious disease and dialysis-related portfolio, including a possible expansion of REZZAYO into fungal infection prophylaxis and continued work to sustain DefenCath uti

MarketBeat

Kyle Busch net worth: Will NASCAR Coca-Cola 600 be postponed or canceled?

Kyle Busch death: NASCAR champion was thought to have had a sinus cold While racing May 10 at Watkins Glen, Busch radioed his team requesting a “shot” from a doctor after he finished.

The Economic Times

Medicare Advantage Company Alignment Healthcare Shows Huge, Unusual Call Option Activity

Alignment Healthcare, a fast-growing Medicare Advantage company, had strong Q1 revenue and adjusted EBITDA results. That may be the underlying reason for the huge, unusual call option activity today.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Dear England playwright praises local BBC radio for supporting first production

Graham appeared before the Culture, Media and Sport Committee (CMS) to discuss the issues facing the BBC.

Evening Standard

Medicare Negotiations Continue: 15 More Drugs Including Weight-Loss Treatments Could See Price Cuts in 2027

Prescription drug costs continue to be one of the biggest financial pressures facing retirees and older Americans. In fact, many Medicare beneficiaries (around 21%) spend...

Saving Advice

GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead

GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who identified himself during the discussion as the company’s CFO, at a Bank of America event. Aaron said t

MarketBeat

CMS’s New AI-Powered Prior Authorization System: Will It Speed Up Approvals or Deny Seniors Critical Care?

For years, seniors and doctors have complained that prior authorization delays can feel like a second illness layered on top of an existing medical problem....

Saving Advice

Read news from The Economist, FT, and more,
with one subscription

Weight-Loss Drugs Wegovy & Foundayo Get Medicare Coverage on July 1, 2026 — Find Out Who Qualifies

For years, many older Americans watched popular weight-loss drugs like Wegovy stay financially out of reach because Medicare would not cover medications prescribed mainly for...

Saving Advice

DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport

DocGo (NASDAQ:DCGO) Chief Executive Officer Lee Bienstock outlined the company’s transition away from COVID-related, migrant and emergency-response programs and toward its “evergreen” medical transportation and mobile health businesses during a presentation at the 21st Annual Needham Technology, Med

MarketBeat

Medicare’s 72-Hour Decision Rule Begins Now: What Seniors Must Know About Faster Approvals and Denials

Millions of seniors enrolled in Medicare Advantage plans have spent years frustrated by delayed prior authorization decisions for medical care, scans, procedures, and treatments. Some...

Saving Advice

Vance’s Medicare crackdown just froze billions in hospice care, but the scheme it uncovered is far darker than a simple billing scam

Vice President J.D. Vance’s Medicare fraud task force just froze billions in hospice care payments, slamming the brakes on new providers nationwide for the next six months. The move, announced on May 13, 2026, is the sharpest crackdown yet on what officials are calling a crisis of exploitation — one…

The Mary Sue

AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam

AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are expected to be positive but have not yet been quantified. Speaking during a company event, Dale said he w

MarketBeat

PACS Group Q1 Earnings Call Highlights

PACS Group (NYSE:PACS) reported a strong start to 2026, with executives citing higher occupancy, improved skilled mix and continued progress integrating acquired facilities as drivers of first-quarter performance. On the company’s earnings call, Chairman and CEO Jason Murray said PACS entered the y

MarketBeat

Trump Wages $1.3 Billion Medicaid War on California and Warns All States Face Total Funding Suspension

The Trump administration has withheld $1.3 billion in Medicaid payments to California and imposed a nationwide freeze on new Medicare provider enrolments, citing healthcare fraud concerns.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

JD Vance threatens health funding to states that don’t comply with White House anti-fraud effort

Medicare has already paused hospice and home healthcare agency signups as potential fraud is investigated

MarketBeat

Sanuwave Health Q1 Earnings Call Highlights

Sanuwave Health (NASDAQ:SNWV) reported record first-quarter revenue and rising consumables utilization, while management said the advanced wound care market began to recover after a difficult start to the year tied to changes in reimbursement for skin substitutes. Chairman and CEO Morgan Frank said

The Independent UK

Trump administration freezes new Medicare enrollments for hospice and home health agencies

The Trump administration is expanding its fraud-busting initiative in federal health programs

Medical Daily

Healthcare Outsourcing Philippines: Why Agentic AI Demands Human Expertise, Not Replacement

Inside the $423+ Billion Global Healthcare Outsourcing Market: How Philippine Clinical Talent Is Solving the Crisis That Autonomous AI Cannot

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Nyxoah Q1 Earnings Call Highlights

Nyxoah (NASDAQ:NYXH) reported 13% sequential worldwide net revenue growth in the first quarter of 2026, driven primarily by continued adoption of its Genio system in the United States, where the company is in its second full quarter of commercialization. Chief Executive Officer Olivier Taelman said

MarketBeat

Fractyl Health Q1 Earnings Call Highlights

Fractyl Health (NASDAQ:GUTS) said it remains on track to report pivotal data for its Revita therapy in early fourth quarter 2026, as management highlighted clinical, regulatory and reimbursement developments during the company’s first-quarter 2026 earnings call. Chief Executive Officer Dr. Harith R

MarketBeat

SiBone Q1 Earnings Call Highlights

SiBone (NASDAQ:SIBN) raised its full-year 2026 outlook after reporting double-digit revenue growth in the first quarter, with management pointing to new product launches, expanding physician adoption, international momentum and a proposed Medicare reimbursement change as key drivers for the year ahe

Saving Advice

The New Medicare Coding Change Confusing Pharmacies Across Multiple States

You likely walk up to the pharmacy counter thinking that it’ll be nothing more than a routine prescription refill. However, many seniors are experiencing more...

MarketBeat

OPAL Fuels Q1 Earnings Call Highlights

OPAL Fuels (NASDAQ:OPAL) said it remains on track to meet its full-year 2026 guidance despite lower first-quarter revenue and adjusted EBITDA, as management pointed to improving renewable natural gas production, stronger environmental credit pricing and growing interest from heavy-duty trucking flee

Saving Advice

Thousands of Seniors May Not Qualify for Medicare’s New Weight-Loss Coverage

For many older Americans struggling with obesity, Medicare’s new GLP-1 weight-loss coverage sounded like long-awaited relief. Drugs like Wegovy and Zepbound have dominated headlines because...

Saving Advice

The New $50 Medicare Weight-Loss Drug Program Has a Catch for Low-Income Seniors

For years, many older Americans watched popular weight-loss drugs like Wegovy and Zepbound dominate headlines while remaining financially out of reach. Monthly costs for GLP-1...

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.